Key facts
- This page summarizes Ted Murphy's Form 4 filing for Co-Diagnostics, Inc. (CODX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 May 2024, 16:01.
Ted Murphy - 23 May 2024 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)
- Reporting relationship
- Director
- Issuer ticker
- CODX
- Reported as of
- 23 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 May 2024, 16:01:36 UTC
- Prior SEC filing
- 29 Apr 2024
- Next SEC filing
- 25 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edward L. Murphy
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ted Murphy filed Form 4 for Co-Diagnostics, Inc. (CODX) on 28 May 2024.
Change
- Previous filing in this sequence was filed on 29 Apr 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CODX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +30,000
- Change %
- +31%
- Price
- $0.000000
- Shares after
- 127,500
- Date
- 23 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CODX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -30,000
- Change %
- -13%
- Price
- $0.000000
- Shares after
- 200,000
- Date
- 23 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 230,000
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Included in 70,000 restricted stock units awarded to the Reporting Person on July 7, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2022. Included in 40,000 restricted stock units awarded to the Reporting Person on January 17, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on May 23, 2023. Included in 70,000 restricted stock units awarded to the Reporting Person on June 12, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2023.